StockData
CEL SCI Corp logo

CEL SCI Corp (CVM) shareholders

CVMNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 1/30
$1.66+0.38 (+29.69%)

Close on Nov 16, 2026Market cap $29.20MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
11.3%
2M of 18M shares
Institutional holders
41
10 new, 7 sold out
Net institutional buying
1M
In Q2 2026
Insider trades, 12 months
5 buys · 0 sales
Net bought $867.00K

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Lincoln Alternative Strategies LLC555,0006.94%13G (passive)Aug 27, 2025

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of CVMValueChange% of portfolio
Renaissance Technologies LLC572,4603.25%$595.36K+536,5700.00%
Vanguard Capital Management LLC543,0793.09%$564.80K+299,4340.00%
Citadel Advisors LLC198,5001.13%$206.44KNew0.00%
MAI Capital Management108,2800.62%$112.61K+17,0000.00%
Geode Capital Management, LLC88,2000.50%$91.78K+2,8890.00%
Commonwealth Equity Services, LLC51,4340.29%$53.49K+33,8120.00%
Hrt Financial LP51,1550.29%$53.00KNew0.00%
Vanguard Fiduciary Trust Co49,0360.28%$51.00K–0.00%
BlackRock, Inc.43,2610.25%$44.99K–0.00%
Bank Of America Corp /De/40,9160.23%$42.55K−810.00%
Jane Street Group, LLC36,4580.21%$37.92KNew0.00%
XTX Topco Ltd34,8880.20%$36.28K+12,3320.00%
Osaic Holdings, Inc.32,7800.19%$34.08K+30,8970.00%
US Bancorp \de\29,9070.17%$31.10K–0.00%
State Street Corp27,2700.16%$28.36K–0.00%
Northern Trust Corp21,0830.12%$21.93K+2,1490.00%
Raymond James Financial Inc16,0130.09%$16.65KNew0.00%
Virtu Financial LLC11,3150.06%$12.00KNew0.00%
Financial Consulate, Inc10,0000.06%$10.40KNew0.00%
HighTower Advisors, LLC10,0000.06%$10.40K–0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 2026412M11.3%10 / 103 / 71M0M
Q1 2026381M4.2%5 / 114 / 60M0M
Q4 2025401M4.2%10 / 108 / 50M0M
Q3 2025351M5.0%8 / 78 / 10M0M
Q2 2025280M2.7%28 / 00 / 00M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

7 funds held CVM in Q2 2026, 88% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of CVMValue% of fundAs of
Vanguard Total Stock Market Index Fund456,9412.60%$475.22K0.00%Jun 30, 2026
Vanguard Extended Market Index Fund86,1380.49%$89.58K0.00%Jun 30, 2026
Fidelity Extended Market Index Fund42,4610.24%$65.39K0.00%May 31, 2026
Fidelity Series Total Market Index Fund12,1640.07%$18.73K0.00%May 31, 2026
Fidelity Total Market Index Fund11,5200.07%$17.74K0.00%May 31, 2026
Ultra-Small Company Market Fund7,5000.04%$7.80K0.01%Jun 30, 2026
Blackstone Alternative Multi-Strategy Fund450.00%$470.00%Jun 30, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Geert R. KerstenChief Executive Officer, Director630,3103.58%Oct 1, 2026
Patricia B. PrichepChief Financial Officer19,5710.11%Oct 1, 2026
Eyal TalorChief Scientific Officer10,4830.06%Oct 1, 2026
John CiprianoSenior Vice President63,1080.36%Aug 17, 2026
Robert Eugene WatsonDirector3,7330.02%Aug 17, 2026
Bruno Jean-Marie BaillavoineDirector5,9730.03%Aug 17, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Eyal Talor
Chief Scientific Officer
Sep 30, 2026Award+1,165$2.06$2.40K10,483
Patricia B. Prichep
Chief Financial Officer
Sep 30, 2026Award+2,082$2.06$4.29K19,571
Geert R. Kersten
Chief Executive Officer, Director
Sep 30, 2026Award+2,621$2.06$5.40K318,763
Geert R. Kersten
Chief Executive Officer, Director
Aug 25, 2026Buy+100,000$1.38$138.00K316,142
Geert R. Kersten
Chief Executive Officer, Director
Jun 30, 2026Award+5,192$1.04$5.40K216,142
Eyal Talor
Chief Scientific Officer
Jun 30, 2026Award+2,307$1.04$2.40K9,318
Patricia B. Prichep
Chief Financial Officer
Jun 30, 2026Award+4,125$1.04$4.29K17,489
Geert R. Kersten
Chief Executive Officer, Director
May 14, 2026Buy+300,000$1.20$360.00K311,547
Geert R. Kersten
Chief Executive Officer, Director
May 13, 2026Buy+100,000$1.19$119.00K222,497
Eyal Talor
Chief Scientific Officer
Mar 31, 2026Award+747$3.21$2.40K7,011
Patricia B. Prichep
Chief Financial Officer
Mar 31, 2026Award+1,336$3.21$4.29K13,364
Geert R. Kersten
Chief Executive Officer, Director
Mar 31, 2026Award+1,682$3.21$5.40K122,497
Geert R. Kersten
Chief Executive Officer, Director
Jan 22, 2026Buy+38,023$5.26$200.00K120,815
Geert R. Kersten
Chief Executive Officer, Director
Dec 31, 2025Award+998$5.26$5.25K82,792
Patricia B. Prichep
Chief Financial Officer
Dec 31, 2025Award+815$5.26$4.29K12,028
Eyal Talor
Chief Scientific Officer
Dec 31, 2025Award+456$5.26$2.40K6,264
Geert R. Kersten
Chief Executive Officer, Director
Dec 4, 2025Buy+8,389$5.96$50.00K81,794
Geert R. Kersten
Chief Executive Officer, Director
Sep 30, 2025Award+570$9.20$5.24K73,405
Patricia B. Prichep
Chief Financial Officer
Sep 30, 2025Award+466$9.20$4.29K11,213
Eyal Talor
Chief Scientific Officer
Sep 30, 2025Award+260$9.20$2.39K5,808
Robert Eugene Watson
Director
Jul 25, 2025Buy+2,919$6.85$20.00K3,733
Geert R. Kersten
Chief Executive Officer, Director
Jul 25, 2025Buy+29,197$6.85$200.00K72,835
Patricia B. Prichep
Chief Financial Officer
Jun 30, 2025Award+1,873$2.29$4.29K10,747
Eyal Talor
Chief Scientific Officer
Jun 30, 2025Award+1,048$2.29$2.40K5,548
Geert R. Kersten
Chief Executive Officer, Director
Jun 30, 2025Award+2,292$2.29$5.25K43,638
Eyal Talor
Chief Scientific Officer
Mar 31, 2025Award+10,416$0.23$2.40K135,013
Geert R. Kersten
Chief Executive Officer, Director
Mar 31, 2025Award+22,786$0.23$5.24K1,240,378
Patricia B. Prichep
Chief Financial Officer
Mar 31, 2025Award+15,432$0.23$3.55K266,230
Eyal Talor
Chief Scientific Officer
Dec 31, 2024Award+6,001$0.40$2.40K124,597
Geert R. Kersten
CEO, Director
Dec 31, 2024Award+12,940$0.40$5.18K1,217,592
Patricia B. Prichep
Chief Financial & Operations
Dec 31, 2024Award+10,727$0.40$4.29K250,798
Geert R. Kersten
Chief Executive Officer, Director
Sep 30, 2024Award+4,882$1.06$5.17K1,204,652
Eyal Talor
Chief Scientific Officer
Sep 30, 2024Award+2,264$1.06$2.40K118,596
Patricia B. Prichep
Sr. VP of Operations
Sep 30, 2024Award+4,047$1.06$4.29K240,071
Geert R. Kersten
Chief Executive Officer, Director
Jun 28, 2024Award+4,461$1.16$5.17K1,199,770
Eyal Talor
Chief Scientific Officer
Jun 28, 2024Award+2,068$1.16$2.40K116,332
Patricia B. Prichep
Senior Vice President
Jun 28, 2024Award+3,698$1.16$4.29K236,024
Robert Eugene Watson
Director
May 8, 2024Buy+20,000$1.39$27.80K24,431
Patricia B. Prichep
Senior Vice President
May 8, 2024Buy+8,000$1.39$11.12K232,326
Geert R. Kersten
Chief Executive Officer, Director
May 8, 2024Buy+30,000$1.39$41.70K1,195,309
Geert R. Kersten
Chief Executive Officer, Director
Mar 29, 2024Award+2,709$1.91$5.17K1,165,309
Patricia B. Prichep
Senior Vice President
Mar 29, 2024Award+2,246$1.91$4.29K224,326
Eyal Talor
Chief Scientific Officer
Mar 29, 2024Award+1,256$1.91$2.40K114,264
Geert R. Kersten
Chief Executive Officer, Director
Dec 29, 2023Award+1,819$2.72$4.95K1,162,600
Patricia B. Prichep
Senior Vice President
Dec 29, 2023Award+1,577$2.72$4.29K222,080
Eyal Talor
Chief Scientific Officer
Dec 29, 2023Award+882$2.72$2.40K113,008
Patricia B. Prichep
Senior Vice President
Sep 29, 2023Award+3,432$1.25$4.29K220,503
Geert R. Kersten
Chief Executive Officer, Director
Sep 29, 2023Award+3,960$1.25$4.95K1,160,781
Eyal Talor
Chief Scientific Officer
Sep 29, 2023Award+1,920$1.25$2.40K112,126
Patricia B. Prichep
Senior Vice President
Jun 30, 2023Award+1,780$2.41$4.29K217,071
Geert R. Kersten
Chief Executive Officer, Director
Jun 30, 2023Award+2,053$2.41$4.95K1,156,821
Eyal Talor
Chief Scientific Officer
Jun 30, 2023Award+995$2.41$2.40K110,206
Geert R. Kersten
Chief Executive Officer, Director
Mar 31, 2023Award+2,133$2.32$4.95K1,154,768
Patricia B. Prichep
Senior Vice President
Mar 31, 2023Award+1,849$2.32$4.29K215,291
Eyal Talor
Chief Scientific Officer
Mar 31, 2023Award+1,034$2.32$2.40K109,211
Patricia B. Prichep
Senior Vice President
Dec 30, 2022Award+1,825$2.35$4.29K213,442
Geert R. Kersten
Chief Executive Officer, Director
Dec 30, 2022Award+1,851$2.35$4.35K1,152,635
Eyal Talor
Chief Scientific Officer
Dec 30, 2022Award+1,021$2.35$2.40K108,177
Daniel H. Zimmerman
Senior Vice President
Sep 30, 2022Award+1,266$3.09$3.91K120,226
Eyal Talor
Chief Scientific Officer
Sep 30, 2022Award+776$3.09$2.40K107,156

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
4.19%
1M shares short
Days to cover
6.0
At 0M shares a day
Change since last report
+6.3%
From 1M shares
Short volume, 20 days
51.4%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Cel Sci's stock actually held short. Settlement fails (shares not delivered on time) peaked at 1,997 shares on Aug 27, 2026 over the last 90 days.

See a number that looks wrong?